Effect of Trimethoprim-Sulfamethoxazole Prophylaxis on Antimicrobial Resistance of Fecal Escherichia coli in HIV-Infected Patients in Tanzania

BACKGROUND: Trimethoprim-sulfamethoxazole (SXT) reduces morbidity and mortality among HIV-infected persons in Africa, but its impact on antimicrobial resistance is of concern. METHODS: HIV-uninfected (group A), HIV-infected but not requiring SXT (group B), and HIV-infected and eligible for SXT (grou...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Morpeth, Susan C., Thielman, Nathan M., Ramadhani, Habib O., Hamilton, John D., Ostermann, Jan, Kisenge, Peter R., Shao, Humphrey J., Reller, L. Barth, Itemba, Dafrosa K., Sam, Noel E., Bartlett, John A., Shao, John F., Crump, John A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2586846/
https://ncbi.nlm.nih.gov/pubmed/18285712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31816856db
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi